Journal of the American College of Cardiology
State-of-the-Art PaperRight Heart Adaptation to Pulmonary Arterial Hypertension: Physiology and Pathobiology
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Vonk-Noordegraaf has received lecture fees from Actelion, Bayer, GlaxoSmithKline, United Therapeutics, Lilly, Pfizer, and Novartis; is on the industry advisory board from Actelion and Bayer; and serves on the steering committee for Actelion, Bayer, and Pfizer. Dr. Chin has received research grants from Actelion, Bayer, Gilead, GlaxoSmithKline, Novartis, United Therapeutics, GeNO, and the National Institutes of Health; and honoraria for service on advisory boards for Actelion, Bayer, and Gilead. Dr. Forfia is a consultant for Actelion and United Therapeutics. Dr. Lumens has received a research grant within the framework of the Dr. E. Dekker Program of the Dutch Heart Foundation (NHS-2012T010). Dr. Oudiz has received grants and research funding, consulting and speaking fees, and honoraria from Actelion, AIRES, Bayer, Gilead, Ikaria, Lung LLC, Pfizer, United Therapeutics. Dr. Provencher has received consulting fees from Actelion, GlaxoSmithKline, Pfizer, and Unither Biotech; research grants from Actelion, Bayer, and GlaxoSmithKline; and speaker fees from Actelion. Dr. Torbicki has received research grants and speaker’s honoraria from Actelion, Bayer, AOP, United Therapeutics, and GlaxoSmithKline; and has served on advisory boards and scientific committees for Actelion, Bayer, AOP, and GlaxoSmithKline. Dr. Voelkel has received grant support for pre-clinical studies from Actelion and United Therapeutics. Dr. Hassoun has participated on advisory boards for Gilead, Merck, Bayer, and Novartis; has received research funding from United Therapeutics for the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management; and his research was supported by grants P50 HL084946 and R01 HL114910 from the National Heart, Lung, and Blood Institute. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Drs. Vonk-Noordegraaf and Haddad contributed equally to this manuscript.